EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance

Jennifer D Zwicker, Ramesh Lamsal, Myla E Moretti, Wendy J Ungar

PharmacoEconomics · 2026-11 · 44 (11) · 1309-1317

DOI: 10.1007/s40273-026-01641-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PharmacoEconomics, online erschienen am 14.07.2026. Verfasst von Jennifer D Zwicker und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Policy, University of Calgary, 906 8th Ave S.W., 5th Floor, Calgary, AB, T2P 1H9, Canada. zwicker1@ucalgary.ca. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Economics, Pharmaceutical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CHILD-BRIGHT, Canada Research Chairs, Kids Brain Health Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodevelopmental disorders are lifelong conditions with onset in early childhood that impair cognitive, social, behavioural and physical functioning. Their consequences extend beyond healthcare, shaping education, social and community services, and family life. Economic evaluations can guide payers by quantifying the value for money of interventions, but standard methods require adaptation for this context. This paper offers practical guidance for pharmacoeconomic evaluations of interventions for children with neurodevelopmental disorders, synthesising methodological literature and applied experience to articulate core challenges, recommend solutions and highlight emerging opportunities. Evaluations must address five inter-related issues: defining and justifying an analytic perspective that captures multi-sectoral costs and benefits; identifying and valuing direct, indirect and intangible costs across health, education and social domains; selecting outcomes sensitive to changes in child functioning and health-related quality of life that can be economically valued; incorporating spillover effects for caregivers and families; and modelling long-term developmental trajectories amid data scarcity and uncertainty. We recommend adopting a societal perspective; applying comprehensive context-appropriate costing; combining generic and condition-specific outcome measures; explicitly including caregiver and family impacts; integrating equity analyses; and using long time horizons supported by robust modelling such as microsimulation or agent-based approaches. Promising directions include capability-based frameworks and digital biomarkers to enable real-world measurement of function and quality of life. Tailored pharmacoeconomic methods are essential for credible policy-relevant evaluations of neurodevelopmental disorder interventions. Transparent reporting and alignment with international standards will improve comparability, support uptake by decision makers, and promote equitable resource allocation for children and families affected by neurodevelopmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodevelopmental DisordersEconomics, PharmaceuticalHumansCost-Benefit AnalysisChildQuality of LifeModels, Economic

Autor:innen und Institutionen

  • School of Public Policy, University of Calgary, 906 8th Ave S.W., 5th Floor, Calgary, AB, T2P 1H9, Canada. zwicker1@ucalgary.ca.
  • Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
  • The Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Förderung

  • CHILD-BRIGHT
  • Canada Research Chairs
  • Kids Brain Health Network

Zitieren

APA

Zwicker, J. D., Lamsal, R., Moretti, M. E., & Ungar, W. J. (2026). Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance. PharmacoEconomics, 44(11), 1309-1317. https://doi.org/10.1007/s40273-026-01641-0

Vancouver

Zwicker JD, Lamsal R, Moretti ME, Ungar WJ. Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance. PharmacoEconomics. 2026;44(11):1309-1317. doi:10.1007/s40273-026-01641-0

BibTeX
@article{Zwicker2026,
  author = {Zwicker, Jennifer D and Lamsal, Ramesh and Moretti, Myla E and Ungar, Wendy J},
  title = {Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Practical Guidance},
  journal = {PharmacoEconomics},
  year = {2026},
  volume = {44},
  number = {11},
  pages = {1309--1317},
  doi = {10.1007/s40273-026-01641-0}
}
Kostenlos starten →